Xero Shares Dip Below A$80, as Recovery Pauses At Resistance

Xero shares (ASX: XRO) slipped below the psychologically important A$80 mark into the weekend break, even as the broader Australian technology sector pushed higher. The pullback tests the strength of a recovery rally that has been building since late July, when the stock hit a multi-year low.

The Xero share price closed out at A$79.37, down 7.32% over the week and still nursing a 49.45% decline over the past 12 months. The drop came on a day when the S&P/ASX Info Tech Index finished 1.0% higher, a divergence that points to profit-taking in Xero rather than any sector-wide sell-off.

Zooming out a little is important here, as despite the weekly slide, the stock remains up 28.9% from its July 24 close of A$61.45, with recent weakness looking more like a cooling-off period after a sharp run than a breakdown in the recovery. A word of caution around the area where the pullback began, as if you hover over the August peak on the 1 year chart below, you will see the high matches the level of March and June this year that has acted as resistance.

Fundamentals Come In Strong

The underlying business continues to deliver strong top-line momentum. Xero’s latest financial disclosures showed operating revenue rising 31% year on year to NZ$2.75 billion, while annualised monthly recurring revenue jumped 37% to NZ$3.27 billion. Average revenue per user climbed 23% to NZ$55.44, and the subscriber base now stands at 4.92 million. Gross margins remain around 88%, underscoring the quality of the subscription model.

The pressure point is profitability. Net profit fell 27% to NZ$167.4 million, largely reflecting integration and investment costs tied to Melio, the US payments business Xero acquired to accelerate its North American push. The deal has shifted the balance sheet from a net cash to a net debt position, though management points to a 240% revenue surge in the key US market as evidence the strategy is gaining traction in a total addressable market estimated at US$100 billion outside Australia and New Zealand.

On the product front, Xero used its Xerocon US event to showcase an expanded AI automation suite built on its JAX platform, with deeper integrations across Microsoft 365, OpenAI’s ChatGPT and Anthropic’s Claude. Management reaffirmed FY27 revenue guidance of NZ$3.62 billion to NZ$3.73 billion, implying roughly 30% year-on-year growth, with early AI feature monetisation expected to lift ARPU further.

There was also a governance development, with Non-Executive Director Anjali Joshi confirming she will not stand for re-election at the 2026 Annual General Meeting after three years on the board. Separately, Xero updated executive compensation benchmarks to better align with global US technology peers, a move aimed at attracting leadership talent for its North American expansion.

What Comes Next For XRO?

Management has reaffirmed its FY27 outlook and framed AI monetisation as central to future ARPU growth, yet analysts remain divided. Morgan Stanley carries a price target of A$130.00, UBS sits at A$127.00 and Citi at A$113.60, implying upside of roughly 38% to 60% from current levels. At the cautious end, RBC Capital holds an A$85 target with a Sector Perform rating, while Jefferies sits at A$77, citing data access fee risks and fierce US competition from the likes of Intuit’s QuickBooks.

XRO holders are now wondering whether the dip below A$80 proves a buying opportunity or a warning sign as the stock pulls back from resistance. The worst of the selling pressure certainly seems to have eased, and the fundamental picture and sentiment surrounding software names has improved, providing a boost. Yet the pain of earlier drawdowns remains fresh in the memory, and down 49.45% over the past 12 months is not exactly a happy place to be.

Bull Case: